Table 3:
Antiplatelet regimen | |
Clopidogrel | 406 (86.7%) |
Ticlopidine | 62 (13.3%) |
Stents used for treatmenta,b | |
Enterprise | 340 (68%) |
Solitaire (Solo) | 98 (19.6%) |
Wingspan | 41 (8.2%) |
LEO | 16 (3.2%) |
Neuroform | 5 (1%) |
Percentages are obtained over the total number of aneurysms treated (n = 500), whereas others are over the number of patients (n = 468).
Stents with technical failure are not included in this table.